Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept.

Costa L, Atteno M, Caso F, Scarpato L, Del Puente A, Scarpa R.

Int J Rheum Dis. 2014 Feb;17(2):219-20. doi: 10.1111/1756-185X.12057. Epub 2013 Apr 4. No abstract available.

PMID:
24576280
[PubMed - indexed for MEDLINE]
2.

Development of Crohn's disease in a patient taking etanercept.

Oh J, Arkfeld DG, Horwitz DA.

J Rheumatol. 2005 Apr;32(4):752-3.

PMID:
15801037
[PubMed - indexed for MEDLINE]
3.

Resident Rounds. Part III B: tumor necrosis factor-α antagonists and alopecia areata: a class-wide adverse effect.

Griffith JL, Ledet JJ, Elewski BE.

J Drugs Dermatol. 2013 Jun 1;12(6):713-4. No abstract available.

PMID:
23839195
[PubMed - indexed for MEDLINE]
4.

Alopecia areata universalis elicited during treatment with adalimumab.

Pelivani N, Hassan AS, Braathen LR, Hunger RE, Yawalkar N.

Dermatology. 2008;216(4):320-3. doi: 10.1159/000113945. Epub 2008 Jan 29.

PMID:
18230980
[PubMed - indexed for MEDLINE]
5.

Giant orf with prolonged recovery in a patient with psoriatic arthritis treated with etanercept.

Rørdam OM, Grimstad Ø, Spigset O, Ryggen K.

Acta Derm Venereol. 2013 Jul 6;93(4):487-8. doi: 10.2340/00015555-1514. No abstract available.

PMID:
23250111
[PubMed - indexed for MEDLINE]
Free Article
6.

Etanercept: An overview.

Goffe B, Cather JC.

J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S105-11. Review.

PMID:
12894133
[PubMed - indexed for MEDLINE]
7.

Alopecia areata during etanercept therapy.

Pan Y, Rao NA.

Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):127-9. doi: 10.1080/09273940802596559.

PMID:
19412875
[PubMed - indexed for MEDLINE]
8.

Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.

Zschoche C, Bidier M, Hadaschik E.

J Dtsch Dermatol Ges. 2013 May;11(5):450-3. doi: 10.1111/ddg.12027. Epub 2013 Jan 2. Review. No abstract available.

PMID:
23279686
[PubMed - indexed for MEDLINE]
9.

Recurrence of alopecia areata in a patient receiving etanercept injections.

Posten W, Swan J.

Arch Dermatol. 2005 Jun;141(6):759-60.

PMID:
15967923
[PubMed - indexed for MEDLINE]
10.

Hepatotoxicity associated with etanercept in psoriatic arthritis.

Leak AM, Rincon-Aznar B.

J Rheumatol. 2008 Nov;35(11):2286-7. doi: 10.3899/jrheum.080521. No abstract available.

PMID:
19004062
[PubMed - indexed for MEDLINE]
Free Article
11.

[Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].

Haake H, Köneke J, Amann K, vom Dahl J, Janssen U.

Med Klin (Munich). 2007 Oct 15;102(10):852-7. German.

PMID:
17928969
[PubMed - indexed for MEDLINE]
12.

Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept).

Yazisiz V, Avci AB, Erbasan F, Yildirim B, Terzioğlu E.

Colorectal Dis. 2008 Nov;10(9):953-4. doi: 10.1111/j.1463-1318.2008.01490.x. Epub 2008 Feb 21.

PMID:
18294265
[PubMed - indexed for MEDLINE]
13.

[Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].

Paul C, Solignac M.

Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):13-5. doi: 10.1016/S0151-9638(10)70012-0. French. No abstract available.

PMID:
20510165
[PubMed - indexed for MEDLINE]
14.

Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists.

Lamrock E, Brown P.

Australas J Dermatol. 2012 Nov;53(4):e87-90. doi: 10.1111/j.1440-0960.2011.00863.x. Epub 2012 Feb 16. Review.

PMID:
23157794
[PubMed - indexed for MEDLINE]
15.

Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study.

Fouache D, Goëb V, Massy-Guillemant N, Avenel G, Bacquet-Deschryver H, Kozyreff-Meurice M, Ménard JF, Muraine M, Savoye G, Le Loët X, Tharasse C, Vittecoq O.

Rheumatology (Oxford). 2009 Jul;48(7):761-4. doi: 10.1093/rheumatology/kep083. Epub 2009 Apr 24.

PMID:
19395543
[PubMed - indexed for MEDLINE]
Free Article
16.

Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature.

Wiegering V, Morbach H, Dick A, Girschick HJ.

Rheumatol Int. 2010 Apr;30(6):801-4. doi: 10.1007/s00296-009-0991-7. Epub 2009 Jun 9. Review.

PMID:
19506877
[PubMed - indexed for MEDLINE]
17.

Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.

Spadaro A, Ceccarelli F, Scrivo R, Valesini G.

Ann Rheum Dis. 2008 Nov;67(11):1650-1. doi: 10.1136/ard.2007.085951. No abstract available.

PMID:
18854519
[PubMed - indexed for MEDLINE]
18.

The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.

Yamauchi PS, Gindi V, Lowe NJ.

Dermatol Clin. 2004 Oct;22(4):449-59, ix. Review.

PMID:
15450340
[PubMed - indexed for MEDLINE]
19.

Immunomodulatory effects of etanercept (TNFR:Fc) and its use in a patient with Crohn's disease.

Srivastava MD.

Res Commun Mol Pathol Pharmacol. 2001 Jul;109(1-2):125-41.

PMID:
11458980
[PubMed - indexed for MEDLINE]
20.

Alopecia areata following adalimumab.

Kirshen C, Kanigsberg N.

J Cutan Med Surg. 2009 Jan-Feb;13(1):48-50.

PMID:
19298772
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk